Exemestane
Also known as Aromasin (us), Xtane (india)
Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods) and who have already been treated with a medication called tamoxifen (Nolvadex) for 2 to 3 years.
United States
$22
per month
India
$9
per month
You save
−59%save $13/mo · 59% cheaper
212.9K US scripts/yr$2.7M potential annual savings$4.6M US spend/yr
Drag to rotate · 3D structureC20H24O2
SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C
Compare the price
US price$22per month
India price$9per month
You save$1359% less
Based on 30 EAs per month. US $0.72 vs India $0.30 per EA.
Total over 1 periodSave $13$22 → $9
The bigger picture
Exemestane is filled about 212.9K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$4.6M
If sourced from India
$1.9M
Potential annual savings
$2.7M
−59%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.